<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
     xmlns:georss="http://www.georss.org/georss"
     xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#"
     xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[FDA gives emergency clearance to Eli Lilly’s experimental COVID-19 antibody treatment]]></title>
        <atom:link href="https://usagag.com/2020/11/09/fda-gives-emergency-clearance-to-eli-lilly-s-experimental-covid-19-antibody-treatment/" rel="self" type="application/rss+xml" />
        <link>https://usagag.com/2020/11/09/fda-gives-emergency-clearance-to-eli-lilly-s-experimental-covid-19-antibody-treatment/</link>
        <lastBuildDate>Mon, 09 Nov 2020 21:47:46 +0000</lastBuildDate>
        <sy:updatePeriod>hourly</sy:updatePeriod>
        <sy:updateFrequency>1</sy:updateFrequency>
        <generator>https://usagag.com</generator>
        <media:content url="/uploads/2020/11/10/fda-gives-emergency-clearance-to-eli-lilly-s-experimental-covid-19-antibody-treatment.jpg" medium="image">
            <media:title type="html">FDA gives emergency clearance to Eli Lilly’s experimental COVID-19 antibody treatment</media:title>
        </media:content>
        <content:encoded><![CDATA[
						<p>The Food and Drug Administration on Monday issued an emergency clearance to Eli Lilly’s experimental COVID-19 antibody treatment.</p>
<p>The drug, praised by President Trump, was proven effective in clinical trials at reducing the need for hospitalizations in coronavirus patients at high risk of disease progression, the FDA said.</p>
<p>Called bamlanivimab, it can be used in the treatment of mild and moderate COVID-19 cases in patients over the age of 12, the agency said.</p>
<p>Trump has said the country would provide the treatment free of cost to Americans.</p>
<p>Last month, Eli Lilly <strong>announced a deal</strong> with the US government over the drug.</p>
<p>The company agreed to provide the government with 300,000 doses of bamlanivimab in exchange for $375 million.</p>
<p>White House spokesman Michael Bars said the treatment can be rolled out immediately. </p>
<p>&#8220;Through continued determination, this treatment and others like it will help protect the health and well-being of millions of vulnerable Americans until a safe and effective vaccine is approved for use,&#8221; Bars said in a statement. </p>
<p><em>With Post wires</em></p>
			
					
						]]></content:encoded>
                <dc:creator><![CDATA[GAGmen]]></dc:creator>
            </channel>
</rss><!--Time: 0.0021908283233643-->